Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071552 · ClinicalTrials.gov registry record · Phase 4
Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients
A Phase 4 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Terminated
- Registry status
- Phase 4
- Development phase
- 49
- Enrollment target
NCT00071552 is a Phase 4 study that was terminated before completion, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 49 participants.
The verdict
NCT00071552, a Phase 4 study, was terminated before completion, sponsored by Teva Branded Pharmaceutical Products R&D.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 49 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effect of Beclomethasone dipropionate HFA on small airways compared to Fluticasone propionate powder for inhalation administered twice daily to poorly controlled asthmatics.
Interventions
- DRUG Flovent Diskus
- DRUG Qvar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2004-01-31 |
| Est. Completion | 2006-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00071552
The ClinicalTrials.gov registry entry for NCT00071552 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Flovent Diskus is the first listed.
NCT00071552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00071552 about?
NCT00071552 is a clinical study titled "Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients". The primary objective of this study is to evaluate the effect of Beclomethasone dipropionate HFA on small airways compared to Fluticasone propionate powder for inhalation administered twice daily to poorly controlled asthmatics.
What is the current status of trial NCT00071552?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2004-01-31. Estimated completion is 2006-07-31.
What interventions are being tested in trial NCT00071552?
The interventions under investigation include: Flovent Diskus (DRUG), Qvar (DRUG).
Who is sponsoring clinical trial NCT00071552?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.